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Abstract
Background: Use of serum creatinine to estimate GFR may lead to underestimation of the association between
self-reported frailty and kidney function. Our objectives were to evaluate the association of measured GFR (mGFR)
with self-reported frailty among patients with CKD and to determine whether self-reported frailty was associated
with death after adjusting for mGFR.
Methods: Participants in the Modification of Diet in Renal Disease study (1989–1993) had GFR measured using
iothalamate clearance (mGFR), and GFR was estimated based on the CKD-EPI creatinine (eGFRcr) and cystatin C
(eGFRcys) equations. We defined self-reported frailty as three or more of: exhaustion, poor physical function, low
physical activity, and low body weight. Death was ascertained through 2007 using the National Death Index and
the United States Renal Data System.
Results: Eight hundred twelve MDRD participants (97 %) had complete data on self-reported frailty (16 %
prevalence, N = 130) and mGFR (mean (SD) 33.1 ± 11.7 ml/min/1.73 m2). Higher GFR was associated with lower
odds of self-reported frailty based on mGFR, (OR 0.71, 95 % CI 0.60–0.86 per 10 ml/min/1.73 m2), eGFRcr (OR 0.80,
95 % CI 0.67–0.94 per 10 ml/min/1.73 m2), and eGFRcys (OR 0.75, 95 % CI 0.62–0.90 per 10 ml/min/1.73 m2). Median
follow-up was 17 (IQR 11–18) years, with 371 deaths. Self-reported frailty was associated with a higher risk of death
(HR 1.71, 95 % CI 1.26–2.30), which was attenuated to a similar degree when mGFR (HR 1.48, 95 % CI 1.08–2.00),
eGFRcr (HR 1.57, 95 % CI 1.15–2.10), or eGFRcys (HR 1.51, 95 % CI 1.10–2.10) was included as an indicator of kidney
function.
Conclusions: We found an inverse association between kidney function and self-reported frailty that was
similar for mGFR, eGFR and eGFRcys. In this relatively healthy cohort of clinical trial participants with CKD,
using serum creatinine to estimate GFR did not substantially alter the association of GFR with self-reported
frailty or of self-reported frailty with death.
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Background
Frailty is more prevalent among patients with CKD
than among individuals with normal kidney function
[1–4], and frailty is also highly prevalent among non-
elderly patients with ESRD [3, 4]. The association between
frailty and adverse clinical outcomes is established in
the ESRD population. Most studies of frailty and
CKD have been among patients with ESRD, in com-
munity cohorts not specifically enriched for CKD [2, 5], or
in CKD cohorts that employ estimates of kidney func-
tion limiting the ability to ascertain the strength of
association between directly measured kidney function
and frailty, independent of comorbidity and other
factors.
The use of serum creatinine to estimate kidney
function could also complicate the problem of asses-
sing the association of kidney function with frailty.
Because muscle wasting associated with frailty, there
is a potential for bias using creatinine based esti-
mates of glomerular filtration rate (eGFR). To our
knowledge there have been no evaluations of the re-
lationship of frailty with kidney disease using direct
measurement of GFR. The Modification of Diet in
Renal Disease (MDRD) study affords a unique op-
portunity to study frailty by self-report among a co-
hort of healthier patients who have stage 3 to 5
CKD not on dialysis. Within this cohort there is a
wide range of directly-measured GFR to assess the
association of kidney function with frailty. The pur-
pose of this study was twofold; first to examine the
association of kidney function with self-reported
frailty, using a direct measure of kidney function and
estimated GFR as a comparison, and second, to de-
termine whether self-reported frailty was associated
with death in this cohort with few comorbidities.
Methods
Study participants
The MDRD Study was a multicenter cooperative
clinical trial designed to determine whether restric-
tion of dietary protein and a low target blood pres-
sure (mean arterial pressure <92 mmHg vs. usual
target blood pressure (<107 mmHg)) reduced the
rate of progression of CKD, irrespective of the na-
ture of the primary underlying process. Patients with
diabetes requiring insulin were excluded [6]. At
baseline, the severity of kidney disease was assessed
by measurement of GFR using iothalamate. Data on
physical function and exercise were collected by
questionnaires. Data from ancillary studies of this
cohort that evaluated C-reactive protein (CRP) as a
predictor of cardiovascular outcomes were included
in this analysis [7]. Mortality outcomes were ac-
quired via direct data collection within the MDRD
study and through linkage with the National Death
Index and the United States Renal Data System
(USRDS) through December 12, 2007. Participants
from MDRD study A and B were combined for the
purpose of this analysis. Only participants with
complete measures of physical functioning and linkage
information were included in analyses (n = 812; 97 %).
Informed consent was obtained from all participants as
part of the original study. The Committee on Human
Research at the University of California - San Francisco
and the Research and Development Committee of the
San Francisco Veterans Affairs Medical Center deemed
this study exempt.
Self-report frailty definition
Our frailty definition was an adaptation of the Fried
Frailty Index that substituted patients’ self-report of
physical function for the direct measures of physical
performance (gait speed and grip strength) that are
part of the original definition. This approach is simi-
lar to that originally developed by Woods et al. [8]
and subsequently applied among patients with end-
stage renal disease [9] and is (henceforth referred to
as “self-reported frailty”) (Appendix). For the exhaus-
tion criterion, participants responded to a symptom
questionnaire that asked “In the past month how
often have you felt lack of pep and energy? Tiring
easily, weakness?” Patients were given one point in
the exhaustion domain if their response to both
questions corresponded to a moderate amount of
time or more. The physical function domain was
ascertained using the MDRD quality of wellbeing
measure, which assessed participants’ ability to
complete activities of daily living (ADLs) similar to
the Rand SF-36 physical function scale. Individuals
who scored in the lowest quartile based on norma-
tive data were allocated two points in the physical
function domain of self-reported frailty. Physical ac-
tivity was assessed using the MDRD Leisure Time
Physical Activity Questionnaire, which measured the
number of times per week each individual performed
walking or other moderate and vigorous activities
during leisure time. After converting physical activity
into total kilocalories (kcal) of activity per week, in-
dividuals in the lowest quintile based on normative
data [10] were allocated 1 point in the physical ac-
tivity domain of self-reported frailty. The baseline as-
sessment of standard body weight was used as a
surrogate for weight loss. Individuals who were less
than 95 % of standard body weight for sex and
height were allocated 1 point in the weight loss/
underweight domain of self-reported frailty. Self-
reported frailty was defined by a score of ≥3 points,
and patients scoring 1 or 2 points were considered
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intermediate frail by self-report from a total of 5
possible points [10].
Measures of kidney function
Assessment of kidney function using clearance of
125I-iothalamate was completed twice during the base-
line period for all participants. We used the average
of the 2 baseline 125I-iothalamate clearance measures
in our analyses (averaged measured GFR; mGFR). We
modeled GFR as a continuous variable and as cat-
egories (≥45 ml/min/1.73 m2, 30 to 44 ml/min/
1.73 m2, ≤ 29 ml/min/1.73 m2). To compare the asso-
ciation of the direct measurement of kidney function
with self-reported frailty to the association of a
creatinine-based estimate (eGFRcr) and cystatin C-
based estimate (eGFRcys) of GFR with self-reported
frailty, we used the Chronic Kidney Disease Epidemi-
ology Collaboration [11] (CKD-EPI) formulas [12]
using the same modeling strategies. We chose to use
the CKD-EPI equation rather than the MDRD equation to
evaluate the association between creatinine-based eGFR
and self-reported frailty to avoid overestimating the simi-
larity between mGFR and eGFRcr in the derivation cohort
for the MDRD equation.
Statistical analysis
Characteristics of participants who were frail by self-
report, intermediate frail by self-report and non-frail
were compared by Wilcoxon rank sum for continuous
variables and chi square for categorical variables. We
treated self-reported frailty as a dichotomous variable
in the analyses comparing the different methods of
measuring GFR with self-reported frailty, similar to
previous studies in CKD and ESRD [2, 4]. In our survival
analysis, self-reported frailty was treated as a three-level
categorical variable (0 = not frail; 1–2 = intermediate frail,
and 3 = frail by self-report) as Fried and others have done
[2, 10, 13]. We used logistic regression modeling to esti-
mate the association of mGFR, eGFRcr, and eGFRcys with
self-reported frailty. With the exception of albumin and
age, covariates included in the model were treated as
continuous variables. Covariates included age (≤40 years,
41–59 years, ≥ 60 years), sex, quartiles of serum albumin
concentration (≤3.84 mg/dL, 3.85–4.01 mg/dL, 4.02–
4.24 mg/dL, ≥4.25 mg/dL), proteinuria, race, BMI, and log
transformed CRP, protein intake and blood pressure group
assignment. We tested for interactions between age
greater than 60 and GFR and for interactions between sex
and GFR in the adjusted models. A sensitivity analysis was
conducted to determine whether associations were inde-
pendent of study group assignment for blood pressure
and protein. In addition, to examine the robustness of our
findings, we examined the potential for non-linearity of
continuous GFR predictors by including quadratic terms
in the models and by examining the cubic splines. We
tested whether the association of GFR with self-reported
frailty differed according to method of GFR assessment by
comparing the c statistics corresponding to areas under
the ROC curves in adjusted models. Cox proportional
hazards models were used to assess the association of
frailty with death; mGFR, eGFRcr and eGFRcys were
included as covariates in separate models. A p-value of
less than 0.05 was considered statistically significant.
Analyses were performed using SAS version 9.4 (SAS
Institute Inc., Cary NC).
Results
Participant characteristics
Of the 840 MDRD participants, 812 had complete
data for the assessment of self-reported frailty and
were included in our analyses. The majority was male
(60.5 %), the median age was 52 (interquartile range
[IQR] 42–61), and a history of hypertension was com-
mon (84 %) (Table 1). As expected based on the
MDRD inclusion criteria, very few participants had a
history of diabetes (5 %). Approximately 21 % of par-
ticipants had an mGFR greater than or equal to
45 ml/min/1.73 m2, 35 % had an mGFR between 30–
44 ml/min/1.73 m2 and 44 % had an mGFR less than
or equal to 29 ml/min/1.73 m2.
Prevalence of frailty
The most common frailty components were low phys-
ical activity (47 %) and poor physical function (23 %),
whereas a smaller proportion of individuals met the
criteria for underweight/weight loss (17 %) and ex-
haustion (13 %). There was a graded association of
the prevalence of the components of self-reported
frailty with GFR category such that individuals in the
lowest GFR category had a higher prevalence of each
of the components of self-reported frailty (Fig. 1). Six-
teen percent of patients were frail by self-report,
53 % were intermediate frail by self-report, and 31 %
were not frail (Table 1). Self-reported frail individuals
were slightly older than non-frail individuals. Self-
reported frail patients were less likely to be male and
less likely to be Caucasian. There were no statistically
significant differences in the prevalence of hyperten-
sion or diabetes among self-reported frail and non-
frail participants.
Association of mGFR with self-reported frailty
In univariate analysis, higher mGFR was associated
with lower odds of self-reported frailty (Table 2). C-
reactive protein was not associated with frailty (OR
1.07, 95 % CI 0.95–1.2 per one log unit, data not
shown) and was therefore not included in our final
models. After adjusting for covariates, the association
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Fig. 1 Prevalence of Frailty Components by mGFR category
Table 1 Participant characteristics
Characteristic Not frail (N = 252) Intermediate frail (N = 430) Frail (N = 130) Total (N = 812) P-Value
Sex, n (%) male 178 (70.6 %) 250 (58.1 %) 63 (48.5 %) 491 (60.5 %) <0.001
Age, years 52 (43.5, 62) 50 (40,60) 56 (47,62) 52 (42,61) <0.001
BMI, kg/m2 28 (3.9) 26.3 (4.6) 27.5 (5) 27 (4.5) <0.001
Systolic blood pressure, mmHG 133 ± 14.7 133 ± 17.9 134 ± 16.7 133 ± 16.7 0.60
Race
Caucasian 224 (89 %) 365 (84.9 %) 100 (76.9 %) 689 (85 %) 0.03
African American 15 (6.0 %) 37 (8.6 %) 12 (9.2 %) 64 (8 %)
Other 13 (5.0 %) 28 (6.5 %) 18 (13.9 %) 59 (7 %)
Renal parameters
Baseline eGFRcys (ml/min/1.73 m2) 33.4 (12.8) 31.5 (12.6) 28 (11.3) 31.5 (12.6) <0.001
Baseline eGFRcr (ml/min/1.73 m2) 34.4 (12.6) 32.9 (12.7) 30.2 (11) 32.9 (12.5) 0.007
Baseline mGFR (ml/min/1.73 m2) 35.1 (11.7) 32.8 (11.9) 30.0 (10.2) 33.1 (11.7) <0.001
mGFR ≤29 ml/min/1.73 m2 86 (34.1 %) 198 (46.0 %) 75 (57.7 %) 359 (44.2 %) <0.001
mGFR 30–44 ml/min/1.73 m2 100 (39.7 %) 141 (32.8 %) 42 (32.3 %) 283 (34.9 %)
mGFR ≥45 ml/min/1.73 m2 66 (26.2 %) 91 (21.2 %) 13 (10.0 %) 170 (20.9 %)
Serum creatinine, mg/dl 2.29 (0.89) 2.37 (0.94) 2.35 (0.82) 2.3 (0.90) 0.36
Serum cystatin C, mg/L, N = 797 2.11 ± 0.66 2.22 ± 0.67 2.36 ± 0.67 2.21 ± 0.67 0.001
Proteinuria, mg/L, N = 786 1.09 ± 1.75 1.1 ± 1.58 1.16 ± 1.91 1.11 ± 1.69 0.87
Additional laboratory parameters
C-reactive protein^, mg/dL 0.24 (0.11,0.47) 0.20 (0.10,0.61) 0.31 (0.13, 0.71) 0.23 (0.11, 0.6) 0.07
Albumin, g/dL 4.03 (0.30) 4.02 (0.35) 4.0 (0.31) 4.02 (0.33) 0.77
Hematocrit, g/dl 40 (4.5) 38.6 (5.2) 38.1 (4.4) 38.8 (4.92) 0.004
Comorbid conditions
Diabetes mellitus 12 (4.8 %) 18 (4.2 %) 12 (9.2 %) 42 (5.2 %) 0.07
Coronary artery disease 22 (8.7 %) 35 (8.1 %) 17 (13.1 %) 74 (9.1 %) 0.22
Hypertension 214 (84.9 %) 355 (82.6 %) 112 (86.2 %) 681 (84 %) 0.53
Etiology of renal disease
Polycystic kidney disease 53 (21 %) 99 (23 %) 21 (16.2 %) 173 (21.3 %) 0.03
Glomerular disease 119 (47 %) 169 (39.3 %) 64 (49.2) 352 (43.3)
Other 80 (32 %) 162 (37.7 %) 45 (34.6 %) 287 (35.3 %)
Abbreviations: BMI Body mass index, Median (25th, 75th percentile) reported for Age. Footnote: ^For measurement of C-Reactive Protein, N = 781
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of mGFR with self-reported frailty remained statisti-
cally significant, with a similar point estimate as in
the univariate analysis (OR 0.71 per 10 ml/min/
1.73 m2, 95 % CI 0.60–0.86) (Table 2). When mGFR
was considered in clinically relevant categories, in
univariate analysis, individuals with mGFR 30–44 ml/
min/1.73 m2 were more likely to be frail by self-
report compared to mGFR ≥45 ml/min/1.73 m2 (OR
2.10 95 % CI 1.09–3.60). In fully adjusted modelling,
this association was attenuated. Individuals with
mGFR ≤29 ml/min/1.73 m2 were more likely to be
frail by self-report than those with mGFR ≥ 45 ml/
min/1.73 m2 (OR 3.40 95 % CI 1.77–6.50) in multi-
variable analysis.
Association of estimated GFR (eGFRcr and eGFRcys) with
self-reported frailty
Associations of eGFRcr with self-reported frailty were
similar to those observed with mGFR. Higher eGFRcr
Table 2 Cross-sectional association of GFR with self-reported frailty in the MDRD trial, using alternative measures of GFR
mGFR eGFRcr eGFRcys*
Odds Ratio (95 % CI) Odds Ratio (95 % CI) Odds Ratio (95 % CI)
Univariate Multivariable Univariate Multivariable Univariate Multivariable
GFR, per 10 ml/min/1.73 m2 0.75 (0.63–0.89) 0.71 (0.60–0.86) 0.81 (0.68–0.94) 0.80 (0.67–0.94) 0.74 (0.62–0.88) 0.75 (0.62–0.90)
GFR in categories
GFR ≥45 (reference) 1.00 – 1.00 – 1.00 –
GFR 30–44 2.10 (1.09–4.00) 1.83 (0.93–3.60) 2.10 (1.04–4.20) 1.77 (0.87–3.60) 1.71 (0.82–3.60) 1.50 (0.70–3.20)
GFR ≤29 3.20 (1.71–5.90) 3.40 (1.77–6.50) 3.30 (1.72–6.50) 3.20 (1.61–6.40) 2.50 (1.25–5.00) 2.30 (1.11–4.70)
Abbreviations: mGFR, measured glomerular filtration rate by Iothalamate; eGFRcr, creatinine estimated glomerular filtration rate; eGFRcys by CKD-EPI equation,*
N = 797. All multivariate models are adjusted for urine protein, sex, age, race, body mass index and albumin quartiles
Fig. 2 Area under the ROC curves. Legend: Model 1 (Base). Frailty, age, sex, BMI, race, proteinuria, serum albumin. Model 2: Base +mGFR, Model 3:
Base + eGFRcr, Model 4: Base + eGFRcys
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was associated with lower odds of self-reported frailty in
univariate and multivariable analysis (OR 0.80 per
10 ml/min/1.73 m2 (95 % CI 0.67–0.94) in multivariable
analysis) (Table 2). When eGFRcr was modeled using
categories, individuals with eGFRcr ≤ 29 ml/min/1.73 m2
were more likely to be frail by self-report (OR 3.20 95 %
CI 1.61–6.40).
Associations of eGFRcys and covariates with self-
reported frailty were slightly lower compared to
those observed with both mGFR and eGFRcr. Higher
eGFRcys was associated with lower odds of self-
reported frailty in univariate and multivariable ana-
lysis (Table 2). When eGFRcys was modeled using
categories, individuals with eGFRcys ≤ 29 ml/min/
1.73 m2 were more likely to be frail by self-report
(OR 2.30 95 % CI 1.11–4.70).
The association between GFR and frailty did not
differ significantly according to age or sex for any
method of assessing GFR (p-values for interactions
>0.05). The potential for non-linearity of the associ-
ation of GFR with frailty was examined using a quad-
ratic term in the above models and by examining
cubic splines, neither of which differed from the lin-
ear models presented. The concordance c statistic
(area under the receiver operating characteristics
[ROC] curve) for predicting frailty by self-report for
the base model was 0. 66 (95 % CI, 0.60 to 0.71)
(Fig. 2, Table 4). Adding mGFR (0.68, 95 % CI, 0.62
to 0.73), eGFRcr (0.67, 95 % CI 0.61 to 0.72) or
eGFRcys (0.67, 95 % CI 0.62 to 0.72) to the model
(as a categorical variables) did not significantly change
the c statistic.
Association of self-reported frailty with risk of death
Three hundred seventy-one (45 %) patients died be-
fore the end of 2007 (median follow-up 17 years (IQR
11–18)). Self-reported frailty was associated with a
higher risk of death in multivariable modeling (HR
1.71 95 % CI 1.26–2.30) when kidney function was
not included as a covariate (Table 3). Additionally
adjusting for mGFR moderately attenuated the associ-
ation of self-reported frailty with death (HR 1.48, CI
1.08–2.00). However, adjusting for either measure of
eGFR yielded similar point estimates (HR 1.57, 95 %
CI 1.15–2.10 for eGFRcr vs HR 1.51, 95 % CI 1.10–
2.10 for eGFRcys). Intermediate self-reported frailty
was also associated with a higher risk of death
(HR1.47, 95 % CI 1.14–1.90 compared to non-frail
participants) (Table 2), and adjustment for mGFR,
eGFRcr, and eGFRcys yielded similar associations
(Table 2).
Discussion
We found a strong association between mGFR and
self-reported frailty, such that patients with better
kidney function were less likely to be frail by self-
report even in healthy clinical trial study participants
with relatively advanced CKD. Although similar when
kidney function was modelled with mGFR or eGFR,
the point estimate was strongest with mGFR. Regard-
less of which GFR variable was used as a covariate,
the hazard ratios for the association of self-reported
frailty with death were similar.
Our examination of associations using mGFR, eGFRcr
and eGFRcys was novel. A common limitation of pre-
vious studies of frailty in the CKD population was the
use of creatinine-based measures of kidney function
[2, 5]. Because muscle mass is associated with serum
creatinine and inversely with frailty, use of creatinine-
based measures of kidney function may produce in-
accurate associations. However, in this study we found
similar associations using mGFR and eGFR. Our
results suggest that the relationship between self-
reported frailty and kidney function may not be
particularly sensitive to method of measurement or
Table 4 Area under the ROC curve (c statistic) for association of
GFR with frailty models
ROC model AUC 95 % Confidence limits P-Value
Base model 0.66 0.60 to 0.71 –
Base model + mGFR 0.68 0.63 to 0.74 0.08
Base model + eGFRcr 0.68 0.63 to 0.73 0.08
Base model + eGFRcys 0.67 0.61 to 0.72 0.40
Table 3 Cox proportional hazard models of the association of self-reported frailty with death
Hazard ratio (95 % CI)
Variables Unadjusted for GFR Adjusted for mGFR Adjusted for eGFRcr Adjusted for eGFRcys
Not frail (reference) 1.00 – – –
Intermediate frail 1.47 (1.14–1.90) 1.43 (1.11–1.83) 1.45 (1.13–1.87) 1.42 (1.10–1.83)
Frail 1.71 (1.26–2.30) 1.48 (1.08–2.00) 1.57 (1.15–2.10) 1.51 (1.10–2.10)
Abbreviations: mGFR measured glomerular filtration rate by Iothalamate, eGFRcr creatinine estimated glomerular filtration rate, eGFRcys by CKD-EPI equation. All
models are adjusted for urine protein, sex, age, race, BMI; body mass index and albumin quartiles and group randomization by diet and blood pressure assignment.
All GFR measures are per 10 ml/min/1.73 m2
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estimation of GFR. Informally comparing the association
of self-reported frailty with all three renal function
measures suggests there was no difference between
the three measures of kidney function. It is possible,
however, that eGFRcr might not perform as well in a
more heterogeneous group of patients with CKD as
might be encountered in a community-based cohort
[13] or in clinical practice and that eGFRcys may
have non-GFR-related variability not observed in
these analyses [14].
Direct comparisons of the prevalence of frailty
across CKD populations are hampered by different
characteristics of the cohorts (e.g., age range) and dif-
ferent definitions of frailty. Specifically, the prevalence
of frailty is higher using definitions based on self-
reported physical function compared to frailty defined
by direct measures of physical performance [15].
Nevertheless, it is interesting that our estimate of
frailty based on self-report is similar to that reported
in the Seattle Kidney Study (SKS), which used an
adapted fried criteria [1, 10]. We found a prevalence
of frailty among MDRD participants of 16 % using a self-
reported physical function based definition, whereas the
frailty prevalence in the Seattle Kidney Study (SKS)
was 14 % (95 % CI 10.5–18.2 %) based on direct
measures of physical performance in a population with
a larger comorbidity burden. Surprisingly, although
MDRD clinical trial participants were healthier and youn-
ger than individuals in typical general elderly and ESRD
cohorts, the prevalence of self-reported frailty among
MDRD participants was double that of community elders
[5, 10] and similar to that of other CKD cohorts with
higher comorbidity burden [2]. As anticipated, the preva-
lence of self-reported frailty among MDRD participants
was less than among ESRD cohorts, in which estimates
range from 42 % to 73 % [3, 4, 15, 16].
The association of the severity of CKD with frailty
has been previously evaluated using estimates of renal
function. Similar to our findings with GFR modeled
continuously, these studies have shown patients with
more severe renal disease to have a higher likelihood
of frailty [1, 13, 17]. To our knowledge, ours is the
first study to test association of GFR with frailty
based on three different methods for assessing renal
function. Our study suggests associations of eGFRcys
with frailty may have a similar magnitude of associ-
ation using directly measured renal function. Thus
studies that have used cystatin C as a measure of
renal function may have provided reasonably cali-
brated findings to estimates using direct renal func-
tion measures [1, 13].
The expectation that frailty would be associated
with a higher risk of death was based on a conceptual
framework in which frailty is a marker of accelerated
loss of functional reserve above and beyond what oc-
curs as a result of kidney disease. Although other co-
hort studies have evaluated the association of frailty
with risk of death among patients with CKD [1, 4,
16], the long period of follow-up in our study was
unique, and our results show that frailty even by self-
report is predictive of adverse outcomes even over
longer term follow up. Self-reported frailty was asso-
ciated with higher mortality independent of kidney
function, raising the possibility that frailty operates
through mechanisms not related to CKD such as in-
flammation, oxidative stress, or endothelial dysfunc-
tion related to CKD or its sequelae [18–21]. Further
research into the role of these processes will be im-
portant to understand the pathophysiology of frailty
in the CKD population.
A number of limitations of our study should be
acknowledged. Our definition of frailty was based on
patients’ self-reported physical function rather than dir-
ect measures of physical performance. We and others
have shown that use of self-reported function identifies
more individuals as frail, but such definitions have been
associated with mortality as in this report [3–5, 8]. We
assessed self-reported frailty at baseline and did not
update frailty status during the long follow-up period,
which may have biased our findings towards less of an
association with death. We used underweight based on
standard criteria in place of the weight loss criterion in
our frailty definition, which likely underestimates the
contribution of this component of frailty [15] MDRD
participants were younger and healthier than the general
CKD population. Although the relative health of the co-
hort helped to minimize potential confounding due to
burden of comorbid disease, the finding that creatinine-
based eGFRcr and mGFR were similarly associated with
self-reported frailty must be considered with caution as
greater differences might be observed in less healthy or
older cohorts. For example, in the CHS, findings were
much stronger with cystatin C than creatinine.
Conclusions
In summary, we found that worse kidney function was
associated with higher prevalence of self-reported frailty
in a cohort with a smaller burden of comorbidities than
is generally present among patients with advanced CKD.
Furthermore, the inverse association between kidney
function and self-reported frailty was similar when kid-
ney function was measured or estimated. Self-reported
frailty was associated with higher risk of death even after
adjusting for kidney function. There is a need for longi-
tudinal and interventional studies to determine whether
intervening on frailty can improve outcomes among
patients with CKD.
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